E2609
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Metabolism and Elimination
Conditions
Metabolism and Elimination
Trial Timeline
Jun 1, 2013 → Mar 1, 2014
NCT ID
NCT01975636About E2609
E2609 is a phase 1 stage product being developed by Eisai for Metabolism and Elimination. The current trial status is completed. This product is registered under clinical trial identifier NCT01975636. Target conditions include Metabolism and Elimination.
What happened to similar drugs?
5 of 20 similar drugs in Metabolism and Elimination were approved
Approved (5) Terminated (2) Active (15)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02859207 | Phase 1 | Completed |
| NCT01975636 | Phase 1 | Completed |
| NCT01716897 | Phase 1 | Completed |
Competing Products
20 competing products in Metabolism and Elimination